Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Actavis, Inc.
Actavis Comments on Filing of DOJ Complaint
December 12th, 2008
Actavis, Inc. said that the Department of Justice, on behalf of the Food and Drug Administration (FDA), has filed a complaint seeking a permanent injunction against the business of its Actavis Totowa LLC subsidiary. The filing comes as the company continues to work to address compliance issues stemming from an inspection of the Actavis Totowa facilities by the FDA earlier this year. Since May 2008, the company has focused entirely on ensuring the quality and integrity of its manufacturing and quality systems. Actavis remains confident that the actions it has taken to remedy the compliance and manufacturing issues at Actavis Totowa will exceed FDA's...
Source: Health Business Week (2008-12-12)
|
